BROWN AND BURK PHILIPPINES INC — Pioglitazone Importer Profile
Pharmaceutical Importer · #19 buyer for Pioglitazone · $593.8K import value · 31 shipments · PHILIPPINES · DGFT Verified
BROWN AND BURK PHILIPPINES INC is the #19 importer of Pioglitazone from India with $593.8K in import value and 31 verified shipments. BROWN AND BURK PHILIPPINES INC holds a 1.1% market share in Pioglitazone imports based in PHILIPPINES. The company sources from 1 verified supplier across 17 formulations shipped to 2 countries. Overall, BROWN AND BURK PHILIPPINES INC imports 2 pharmaceutical products worth $887.9K across 1 therapeutic categories.
BROWN AND BURK PHILIPPINES INC — Pioglitazone Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Pioglitazone to BROWN AND BURK PHILIPPINES INC?
Verified from 31 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MICRO LABS LIMITED | $593.8K | 31 | 100.0% |
BROWN AND BURK PHILIPPINES INC sources Pioglitazone from 1 verified Indian supplier based on 31 customs records. The primary supplier is MICRO LABS LIMITED accounting for 100.0% of imports.
Where Does BROWN AND BURK PHILIPPINES INC Import Pioglitazone To?
Destination countries from 31 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $436.7K | 14 | 73.5% |
| UNITED KINGDOM | $157.1K | 17 | 26.5% |
BROWN AND BURK PHILIPPINES INC imports Pioglitazone to 2 countries. The primary destination is PHILIPPINES receiving 73.5% of shipments worth $436.7K.
What Pioglitazone Formulations Does BROWN AND BURK PHILIPPINES INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| PIOGLITAZONE 30 MG TABLETS (IN BB LIVERY | $104.4K | 8 |
| TRIPRIDE 2 ( (Glimepiride + Pioglitazone | $50.0K | 1 |
| TRIPRIDE 2 (GLIMEPIRIDE 2MG, PIOGLITAZONE HCL 15MG, METFORMIN HCL 500MG TABLETS)(1X10s) - TAX INVOICE NO: 705202586 DT: | $50.0K | 1 |
| TRIPRIDE 2 (GLIMEPIRIDE 2MG, PIOGLITAZONE HCL 15MG, METFORMIN HCL 500MG TABLETS)(3X10?S) (QTY-26003.000) TAX INV NO: 70 | $50.0K | 1 |
| TRIPRIDE 2 Glimepiride 2mg + Pioglitazone HCL 15mg + Metformin HCL 500mg TABLETS 1X10S QTY - 51681.000 | $43.7K | 1 |
| PIOGLITAZONE 45 MG TABLETS (IN BB LIVERY | $42.7K | 8 |
| TRIPRIDE 2 GLIMEPIRIDE 2MG + PIOGLITAZONE HCL 15MG + METFORMIN HCL 500MG TABLETS 1X10'S QTY-38788 TAX DOCUMENT NO: 705202 | $35.6K | 1 |
| TRIPRIDE 2 ( (GLIMEPIRIDE 2MG + PIOGLITAZONE HCL 15MG + METFORMIN HCL 500MG TABLETS ) ( 1X10S ) ( QTY- 41655 ) | $35.3K | 1 |
| TRIPRIDE 2 ( (GLIMEPIRIDE 2MG + PIOGLITAZONE HCL 15MG + METFORMIN HCL 500MG TABLETS ) ( 1X10S ) ( QTY- 39265.000 ) | $33.3K | 1 |
| TRIPRIDE 2 ( (GLIMEPIRIDE 2MG + PIOGLITAZONE HCL 15MG + METFORMIN HCL 500MG TABLETS ) ( 1X10S ) ( QTY- 35190.000 ) | $29.9K | 1 |
BROWN AND BURK PHILIPPINES INC imports 17 distinct Pioglitazone formulations from India. The top formulation is PIOGLITAZONE 30 MG TABLETS (IN BB LIVERY with 8 shipments worth $104.4K.
Who Are the Top Buyers of Pioglitazone from India and How Much Does BROWN AND BURK PHILIPPINES INC Import?
India exported $21.0M worth of Pioglitazone through 2,674 shipments from 115 suppliers to 70 countries, serving 293 buyers globally. BROWN AND BURK PHILIPPINES INC imports $593.8K of this total, accounting for 1.1% of India's Pioglitazone exports with 31 shipments from PHILIPPINES. This is verified from 31 customs shipment records covering 17 distinct formulations.
What Is the Average Order Value for BROWN AND BURK PHILIPPINES INC's Pioglitazone Imports?
BROWN AND BURK PHILIPPINES INC's average Pioglitazone order value is $19.2K per consignment, based on 31 shipments totaling $593.8K. BROWN AND BURK PHILIPPINES INC is based in PHILIPPINES and ranks #19 among all Pioglitazone importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Pioglitazone to BROWN AND BURK PHILIPPINES INC?
BROWN AND BURK PHILIPPINES INC sources Pioglitazone from 1 verified Indian supplier: MICRO LABS LIMITED ($593.8K, 100.0%). This is based on 31 customs records.
How Does BROWN AND BURK PHILIPPINES INC Compare to Other Pioglitazone Importers?
BROWN AND BURK PHILIPPINES INC ranks #19 among 293 Pioglitazone importers from India with a 1.1% market share. The top 3 importers are RISING PHARMA HOLDINGS, INC. ,. ($2.8M), RISING PHARMA HOLDINGS, INC. ($2.6M), AUROLOGISTICS LLC (AUROBINDO PHARMA ($2.4M). BROWN AND BURK PHILIPPINES INC processed 31 shipments from PHILIPPINES.
What Other Diabetes & Endocrine Products Does BROWN AND BURK PHILIPPINES INC Import?
BROWN AND BURK PHILIPPINES INC also imports these diabetes & endocrine products. Each links to the detailed product page.
About BROWN AND BURK PHILIPPINES INC
BROWN AND BURK PHILIPPINES INC imports 2 products worth $887.9K. Beyond Pioglitazone, top products include Glimepiride. View the complete BROWN AND BURK PHILIPPINES INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pioglitazone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pioglitazone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BROWN AND BURK PHILIPPINES INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BROWN AND BURK PHILIPPINES INC's capped import value divided by total capped export value for Pioglitazone across all Indian exporters.
- 5.Verified Records: This page is backed by 31 individual customs records matching BROWN AND BURK PHILIPPINES INC importing Pioglitazone, covering 17 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 70+ countries, 293+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pioglitazone Import Data for BROWN AND BURK PHILIPPINES INC
Access order-level details, pricing data, supplier connections, and competitive analysis for BROWN AND BURK PHILIPPINES INC's Pioglitazone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BROWN AND BURK PHILIPPINES INC
Full Company Profile →
2 products · $887.9K total trade · 1 categories
BROWN AND BURK PHILIPPINES INC × Pioglitazone
Verified from customs records
Company Overview
Top Products by BROWN AND BURK PHILIPPINES INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BROWN AND BURK PHILIPPINES INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pioglitazone. For current order-level data, contact TransData Nexus.